Countouriotis Athena has filed 10 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 67546 shares of IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) on June 13, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 67546 | $0.00 | 67,546.0000 | 322,868 | 9999.99% | 20.92% |
| May 28, 2025 | Passage BIO, Inc. | $PASG | Countouriotis Athena | Not found | A | Director Stock Option (right to buy) | 201857 | $0.00 | 201,857.0000 | 62,109,991 | 9999.99% | 0.33% |
| May 20, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Countouriotis Athena | Director | A | Common Stock | 6650 | $0.00 | 13,550.0000 | 196,708,000 | 96.38% | 0.00% |
| June 11, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 49303 | $0.00 | 49,303.0000 | 266,220 | 9999.99% | 18.52% |
| May 21, 2024 | Passage BIO, Inc. | $PASG | Countouriotis Athena | Not found | A | Director Stock Option (right to buy) | 47693 | $0.00 | 47,693.0000 | 56,295,540 | 9999.99% | 0.08% |
| May 21, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Countouriotis Athena | Director | A | Common Stock | 4720 | $0.00 | 6,900.0000 | 191,595,000 | 216.51% | 0.00% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 50000 | $0.00 | 50,000.0000 | 235,131 | 9999.99% | 21.27% |
| Dec. 27, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Countouriotis Athena | Director | A | Common Stock | 2180 | $0.00 | 2,180.0000 | 188,963,000 | 9999.99% | 0.00% |
| June 6, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Countouriotis Athena | Director | A | Deferred Restricted Stock Unit | 51955 | $0.00 | 51,955.0000 | 213,694,000 | 9999.99% | 0.02% |
| May 25, 2023 | Passage BIO, Inc. | $PASG | Countouriotis Athena | Director | A | Director Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 54,618,799 | 9999.99% | 0.04% |